ArticleInternational journal of health geographics2026
Spatial downscaling of multivariate disease risk.
Article in International journal of health geographics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Downscaling areal health data to a finer resolution is important for understanding the intricate spatial patterns of disease. It helps to identify shared risk factors and to develop targeted public health interventions. This paper introduces Area-to-Area (ATA) and Area-to-Point (ATP) Poisson cokriging for downscaling spatial disease risks from aggregated areal data. The methodology addresses key challenges by incorporating correlation between the diseases, adjusting for population heterogeneity, and the varying shapes and sizes of the spatial entities. Simulation studies demonstrate the superior performance of ATA and ATP Poisson cokriging compared to their univariate counterparts. We achieved lower mean squared prediction errors and better preserved small-scale spatial variations. The methods are applied to COVID-19 and asthma occurrences in Bogota, Colombia. They reveal more detailed hotspots and coldspots and refined estimates of COVID-19 risk by leveraging its correlation with asthma. Our methods offer advantages in multivariate disease mapping by enabling more accurate risk assessment, improved small-area estimation, and enhanced understanding of spatial disease patterns. Their ability to downscale risks for multiple diseases simultaneously provides valuable insights for targeted public health interventions and resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.